{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T02:47:55Z","timestamp":1791254875471,"version":"4.1.0"},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"SI","license":[{"start":{"date-parts":[[2020,12,28]],"date-time":"2020-12-28T00:00:00Z","timestamp":1609113600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Eli-Lilly and Galderma"},{"DOI":"10.13039\/501100006304","name":"Aalborg University Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006304","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,10,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>To estimate the incidence of COVID-19 hospitalization in patients with inflammatory rheumatic disease (IRD); in patients with RA treated with specific DMARDs; and the incidence of severe COVID-19 infection among hospitalized patients with RA.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A nationwide cohort study from Denmark between 1 March and 12 August 2020. The adjusted incidence of COVID-19 hospitalization was estimated for patients with RA; spondyloarthritis including psoriatic arthritis; connective tissue disease; vasculitides; and non-IRD individuals. Further, the incidence of COVID-19 hospitalization was estimated for patients with RA treated and non-treated with TNF-inhibitors, HCQ or glucocorticoids, respectively. Lastly, the incidence of severe COVID-19 infection (intensive care, acute respiratory distress syndrome or death) among hospital-admitted patients was estimated for RA and non-IRD sp - individudals.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Patients with IRD (n\u2009=\u200958\u00a0052) had an increased partially adjusted incidence of hospitalization with COVID-19 compared with the 4.5 million people in the general population [hazard ratio (HR) 1.46, 95% CI: 1.15, 1.86] with strongest associations for patients with RA (n\u2009=\u200929\u00a0440, HR 1.72, 95% CI: 1.29, 2.30) and vasculitides (n\u2009=\u20094072, HR 1.82, 95% CI: 0.91, 3.64). There was no increased incidence of COVID-19 hospitalization associated with TNF-inhibitor, HCQ nor glucocorticoid use. COVID-19 admitted patients with RA had a HR of 1.43 (95% CI: 0.80, 2.53) for a severe outcome.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Patients with IRD were more likely to be admitted with COVID-19 than the general population, and COVID-19 admitted patients with RA could be at higher risk of a severe outcome. Treatment with specific DMARDs did not affect the risk of hospitalization.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keaa897","type":"journal-article","created":{"date-parts":[[2020,12,12]],"date-time":"2020-12-12T06:22:55Z","timestamp":1607754175000},"page":"SI59-SI67","source":"Crossref","is-referenced-by-count":109,"title":["Incidence and severeness of COVID-19 hospitalization in patients with inflammatory rheumatic disease: a nationwide cohort study from Denmark"],"prefix":"10.1093","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5271-2574","authenticated-orcid":false,"given":"Ren\u00e9","family":"Cordtz","sequence":"first","affiliation":[{"name":"Department of Rheumatology, Aalborg University Hospital, Aalborg, Denmark"},{"name":"Department of Rheumatology, Center for Rheumatology and Spine Diseases, Gentofte Hospital, Hellerup, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesper","family":"Lindhardsen","sequence":"additional","affiliation":[{"name":"Lupus and Vasculitis Clinic, Center for Rheumatology and Spine Diseases, Rigshospitalet, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bolette G","family":"Soussi","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Aalborg University Hospital, Aalborg, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3385-0784","authenticated-orcid":false,"given":"Jonathan","family":"Vela","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Aalborg University Hospital, Aalborg, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4047-7175","authenticated-orcid":false,"given":"Line","family":"Uhrenholt","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Aalborg University Hospital, Aalborg, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasmus","family":"Westermann","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Aalborg University Hospital, Aalborg, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salome","family":"Kristensen","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Aalborg University Hospital, Aalborg, Denmark"},{"name":"Department of Clinical Medicine, Aalborg University, Aalborg, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Nielsen","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Aalborg University Hospital, Aalborg, Denmark"},{"name":"Department of Clinical Medicine, Aalborg University, Aalborg, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Torp-Pedersen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Nordsj\u00e6llands Hospital, Hillerod, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lene","family":"Dreyer","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Aalborg University Hospital, Aalborg, Denmark"},{"name":"Department of Clinical Medicine, Aalborg University, Aalborg, Denmark"},{"name":"The DANBIO Register, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,12,28]]},"reference":[{"key":"2021101018332711200_keaa897-B1","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1093\/ije\/dyaa140","article-title":"Characteristics and predictors of hospitalization and death in the first 11 122 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: a nationwide cohort","volume":"49","author":"Reilev","year":"2020","journal-title":"Int J Epidemiol"},{"key":"2021101018332711200_keaa897-B2","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/rheumatology\/kes305","article-title":"The risk of infections associated with rheumatoid arthritis, with its comorbidity and treatment","volume":"52","author":"Listing","year":"2013","journal-title":"Rheumatology"},{"key":"2021101018332711200_keaa897-B3","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s10067-006-0441-9","article-title":"Infection-related morbidity and mortality in patients with connective tissue diseases: a systematic review","volume":"26","author":"Falagas","year":"2007","journal-title":"Clin Rheumatol"},{"key":"2021101018332711200_keaa897-B4","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1136\/annrheumdis-2020-219217","article-title":"Trajectories of COVID-19 information in the Annals of the Rheumatic Diseases: the first months of the pandemic","volume":"80","author":"Lauper","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"2021101018332711200_keaa897-B5","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1136\/annrheumdis-2020-217763","article-title":"Prevalence of hospital PCR-confirmed COVID-19 cases in patients with chronic inflammatory and autoimmune rheumatic diseases","volume":"79","author":"Pablos","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"2021101018332711200_keaa897-B6","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2020-218152","article-title":"Incidence of severe COVID-19 in a Spanish cohort of 1037 patients with rheumatic diseases treated with biologics and JAK-inhibitors","author":"Jovani","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"2021101018332711200_keaa897-B7","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1136\/annrheumdis-2020-217984","article-title":"Risk factors for hospital admissions related to COVID-19 in patients with autoimmune inflammatory rheumatic diseases","volume":"79","author":"Freites Nu\u00f1ez","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"2021101018332711200_keaa897-B8","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1056\/NEJMc2009567","article-title":"Covid-19 in immune-mediated inflammatory diseases \u2013 case series from New York","volume":"383","author":"Haberman","year":"2020","journal-title":"N Engl J Med"},{"key":"2021101018332711200_keaa897-B9","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1136\/annrheumdis-2020-217627","article-title":"Clinical features of rheumatic patients infected with COVID-19 in Wuhan, China","volume":"79","author":"Ye","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"2021101018332711200_keaa897-B10","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2020-217615","article-title":"What is the true incidence of COVID-19 in patients with rheumatic diseases?","volume":"80","author":"Favalli","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"2021101018332711200_keaa897-B11","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s10654-014-9930-3","article-title":"The Danish Civil Registration System as a tool in epidemiology","volume":"29","author":"Schmidt","year":"2014","journal-title":"Eur J Epidemiol"},{"key":"2021101018332711200_keaa897-B12","doi-asserted-by":"crossref","first-page":"737","DOI":"10.2147\/CLEP.S99490","article-title":"The Danish nationwide clinical register for patients with rheumatoid arthritis: DANBIO","volume":"8","author":"Ibfelt","year":"2016","journal-title":"Clin Epidemiol"},{"key":"2021101018332711200_keaa897-B13","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2147\/CLEP.S91125","article-title":"The Danish National Patient Registry: a review of content, data quality, and research potential","volume":"7","author":"Schmidt","year":"2015","journal-title":"Clin Epidemiol"},{"key":"2021101018332711200_keaa897-B14","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2147\/CLEP.S37587","article-title":"Existing data sources for clinical epidemiology: the Danish National database of reimbursed prescriptions","volume":"4","author":"Johannesdottir","year":"2012","journal-title":"Clin Epidemiol"},{"key":"2021101018332711200_keaa897-B15","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1001\/jama.2020.11301","article-title":"Association of angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use with COVID-19 diagnosis and mortality","volume":"324","author":"Fosb\u00f8l","year":"2020","journal-title":"JAMA"},{"key":"2021101018332711200_keaa897-B16","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1097\/01.EDE.0000081989.82616.7d","article-title":"Marginal structural models as a tool for standardization","volume":"14","author":"Sato","year":"2003","journal-title":"Epidemiology"},{"key":"2021101018332711200_keaa897-B17","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1136\/annrheumdis-2020-217888","article-title":"Clinical characteristics and outcomes of patients with coronavirus disease 2019 (COVID-19) and rheumatic disease: a comparative cohort study from a US \u201chot spot\u201d","volume":"79","author":"D\u2019Silva","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"2021101018332711200_keaa897-B18","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1136\/annrheumdis-2020-218296","article-title":"Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: a multicentric matched cohort study","volume":"79","author":"Pablos","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"2021101018332711200_keaa897-B19","doi-asserted-by":"crossref","first-page":"e689","DOI":"10.1016\/S2665-9913(20)30305-2","article-title":"RJ. Long-term hydroxychloroquine use in patients with rheumatic conditions and development of SARS-CoV-2 infection: a retrospective cohort study","volume":"2","author":"Gentry","year":"2020","journal-title":"Lancet Rheumatol"},{"key":"2021101018332711200_keaa897-B20","first-page":"1","article-title":"Comment on \u201cBaseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19\u201d by Konig et al. Long-term exposure to hydroxychloroquine or chloroquine and the risk of hospitalisation with COVID-1","author":"Sbidian","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"2021101018332711200_keaa897-B21","doi-asserted-by":"crossref","first-page":"563","DOI":"10.2147\/CLEP.S179083","article-title":"The Danish health care system and epidemiological research: from health care contacts to database records","volume":"11","author":"Schmidt","year":"2019","journal-title":"Clin Epidemiol"},{"key":"2021101018332711200_keaa897-B22","doi-asserted-by":"crossref","first-page":"e583\u20135","DOI":"10.1016\/S2665-9913(20)30286-1","article-title":"Patients with rheumatic diseases adhere to COVID-19 isolation measures more strictly than the general population","volume":"2","author":"Hooijberg","year":"2020","journal-title":"Lancet Rheumatol"},{"key":"2021101018332711200_keaa897-B23","doi-asserted-by":"crossref","first-page":"627","DOI":"10.2147\/CLEP.S141438","article-title":"Validity and completeness of rheumatoid arthritis diagnoses in the nationwide DANBIO clinical register and the Danish national patient registry","volume":"9","author":"Ibfelt","year":"2017","journal-title":"Clin Epidemiol"},{"key":"2021101018332711200_keaa897-B24","doi-asserted-by":"crossref","first-page":"731","DOI":"10.2147\/CLEP.S258219","article-title":"Positive predictive value of the giant cell arteritis diagnosis in the danish national patient registry: a validation study","volume":"12","author":"Hjort","year":"2020","journal-title":"Clin Epidemiol"},{"key":"2021101018332711200_keaa897-B25","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.3899\/jrheum.151221","article-title":"Incidence of systemic lupus erythematosus and lupus nephritis in Denmark: a nationwide cohort study","volume":"43","author":"Hermansen","year":"2016","journal-title":"J Rheumatol"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keaa897\/35199462\/keaa897.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/SI\/SI59\/40544642\/keaa897.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/SI\/SI59\/40544642\/keaa897.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,11]],"date-time":"2021-10-11T02:51:01Z","timestamp":1633920661000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/60\/SI\/SI59\/6053804"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,28]]},"references-count":25,"journal-issue":{"issue":"SI","published-online":{"date-parts":[[2020,12,28]]},"published-print":{"date-parts":[[2021,10,9]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keaa897","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,10,1]]},"published":{"date-parts":[[2020,12,28]]}}}